These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis. Seibel MJ; Cosman F; Shen V; Gordon S; Dempster DW; Ratcliffe A; Lindsay R J Bone Miner Res; 1993 Jul; 8(7):881-9. PubMed ID: 8352070 [TBL] [Abstract][Full Text] [Related]
23. Urinary hydroxy-pyridinium crosslinks provide indices of cartilage and bone involvement in arthritic diseases. Seibel MJ; Duncan A; Robins SP J Rheumatol; 1989 Jul; 16(7):964-70. PubMed ID: 2769668 [TBL] [Abstract][Full Text] [Related]
24. Quantitation of biochemical markers of bone resorption following strontium-89-chloride therapy for metastatic prostatic carcinoma. Papatheofanis FJ J Nucl Med; 1997 Aug; 38(8):1175-9. PubMed ID: 9255144 [TBL] [Abstract][Full Text] [Related]
25. Simultaneous free and glycosylated pyridinium crosslink determination in urine: validation of an HPLC-fluorescence method using a deoxypyridinoline homologue as internal standard. Monticelli E; Aman CS; Costa ML; Rota P; Bogdan D; Allevi P; Cighetti G J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Sep; 879(26):2764-71. PubMed ID: 21855424 [TBL] [Abstract][Full Text] [Related]
26. [Deoxypyridinoline and other biochemical markers of bone resorption in distinct pathologies]. Rivero Marcotegui A; Palacios Sarrasqueta M; Grijalba Uche A; Martínez Rodríguez JL; Sorbet Zubiría MJ; García Merlo S Rev Clin Esp; 1997 Jun; 197(6):389-92. PubMed ID: 9304127 [TBL] [Abstract][Full Text] [Related]
27. Usefulness of pyridinium crosslinks and CA 15-3 as markers in metastatic bone breast carcinoma. Massidda B; Ionta MT; Foddi MR; Mascia L; Bruder F; Aloi MB; Meleddu C; Giannoni MN Anticancer Res; 1996; 16(4B):2221-3. PubMed ID: 8694547 [TBL] [Abstract][Full Text] [Related]
28. First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma. Tosi P; Zamagni E; Cellini C; Parente R; Cangini D; Tacchetti P; Perrone G; Ceccolini M; Boni P; Tura S; Baccarani M; Cavo M Eur J Haematol; 2006 May; 76(5):399-404. PubMed ID: 16480429 [TBL] [Abstract][Full Text] [Related]
29. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy? Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729 [TBL] [Abstract][Full Text] [Related]
30. Is there a psoriatic osteopathy? -- the activity of bone resorption in psoriatics is related to inflammatory joint process. Hein G; Schmidt F; Barta U; Müller A Eur J Med Res; 1999 May; 4(5):187-92. PubMed ID: 10336408 [TBL] [Abstract][Full Text] [Related]
31. The effect of D-003 (10 mg/day) on biochemical parameters of bone remodelling in postmenopausal women: a randomized, double-blind study. Ceballos A; Mas R; Castaño G; Fernández L; Mendoza S; Menéndez R; González JJ; Illnait J; Gámez R; Mesa M; Fernández J Int J Clin Pharmacol Res; 2005; 25(4):175-86. PubMed ID: 16402634 [TBL] [Abstract][Full Text] [Related]
32. Posture, age, menopause, and osteopenia do not influence the circadian variation in the urinary excretion of pyridinium crosslinks. Schlemmer A; Hassager C; Pedersen BJ; Christiansen C J Bone Miner Res; 1994 Dec; 9(12):1883-8. PubMed ID: 7872053 [TBL] [Abstract][Full Text] [Related]
33. The acute effects of exercise on bone turnover. Welsh L; Rutherford OM; James I; Crowley C; Comer M; Wolman R Int J Sports Med; 1997 May; 18(4):247-51. PubMed ID: 9231839 [TBL] [Abstract][Full Text] [Related]